Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions highlight the importance of understanding protein misfolding mechanisms, with users describing the research as 'crucial' and discussing how it could lead to breakthroughs in diagnosing and treating diseases like Alzheimer's and Parkinson’s. The tone reflects a blend of curiosity and optimism, emphasizing the potential consequences of further research in this field.
Most discussions recognize the significance of the research on misfolded proteins and their role in diseases, showing general support for the publication's findings.
The use of terms like 'fascinating' and 'important' indicates high interest, especially among those interested in neurodegenerative diseases.
Several discussions delve into the mechanisms and implications, referencing specific proteins and disease transmission, indicating a moderate level of engagement.
Participants seem to acknowledge that this research could influence future studies and medical approaches, though the overall impact is seen as promising but not revolutionary yet.
Misfolded protein aggregates: mechanisms, structures and potential for disease transmission - PubMed https://t.co/pUlqjwjfXk
@Parsifaler 2011 https://t.co/ZslT0AGDp4 "Misfolded Protein Aggregates: Mechanisms, Structures and Potential for Disease Transmission" https://t.co/WS9batMhFz
Proteins are not randomly arranged but are intricately folded into specific structures. This video explains how protein folding occurs, its importance, and its implications for diseases caused by misfolded proteins…
Proteins do not diffuse randomly within cells; they fold into highly specific structures. This video explains how and why proteins fold and misfold, their role in diseases like Alzheimer’s and Parkinson’s, and the…
@Parsifaler 2011 https://t.co/ZslT0AGDp4 "Misfolded Protein Aggregates: Mechanisms, Structures and Potential for Disease Transmission" https://t.co/WS9batMhFz
Misfolded protein aggregates: mechanisms, structures and potential for disease transmission - PubMed https://t.co/pUlqjwjfXk
doi:10.1016/j.semcdb. 2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially modulating protein ...
doi: 10.1016/j.semcdb.2011.04.002 and Hofman, A. (1997). Atrial fibrillation and dementia in a population-based. Morris, M. C., Tangney, C. C., Wang, Y ...
doi:10. '23). Association for Computing Machinery, New York, NY, USA, 174–188. doi:10. 1016/j.semcdb.2019.12.015 ... doi:10.1016/j.apenergy.2015.04.071 [157] ...
https://doi.org/10.1016/J.YGCEN.2011.04.002. Gioacchini G, Lombardo F ... https://doi.org/10.1016/j.semcdb.2006.02.007. Mozingo NM, Vacquier VD ...
doi:10.1016/j.semcdb.2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially ...
doi:10.1016/j.semcdb.2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially ...
doi:10.1016/j.semcdb. 2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Moleculaire chaperonnes neutraliseren proteotoxiciteit door ...
doi:10.1016/j.semcdb. 2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Moleculaire chaperonnes neutraliseren proteotoxiciteit door ...
doi:10.1016/j.semcdb. 2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Moleculaire chaperonnes neutraliseren proteotoxiciteit door ...
doi:10.1016/j.semcdb.2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially ...
doi:10.1016/j.semcdb.2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially ...
doi:10.1016/j.semcdb.2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially ...
doi:10.1016/j.semcdb.2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially ...
doi:10.1016/j.semcdb.2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially ...
doi:10.1016/j.semcdb.2011.04.002 [2] Douglas PM, Summers DW, Cyr DM. Molecular chaperones antagonize proteotoxicity by differentially ...
... 10.1016/j.semcdb.2014.04.002. 24. Paez JG et al (2004) EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy ...
Z
L